Search - tctmd.com

Displaying 561 - 580 of 595

Sort: Relevancy | Date

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Caitlin E. Cox

May 27, 2011

News Daily News

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

May 27, 2011

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

Caitlin E. Cox

May 18, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

Advertisement

ESC Congress 2011: Drugs, Devices Work Together

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

Poor Association Between Stent Thrombosis, Platelet Function Tests

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

After GRAVITAS: Is There a Future for Functional Platelet Testing?

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

Different Agents Show Potential as Adjuncts to PCI

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content